Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Realty Income Corp (O) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Realty Income Corp — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Realty Income Corp trades at $55.85 (market cap $52.20B). The key difference: Realty Income Corp is far larger — about 5.9× Kymera Therapeutics Inc. Common Stock's market cap, and Realty Income Corp pays a 5.91% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Realty Income Corp for 128 Days on average.
| KYMR | O | |
|---|---|---|
Market Cap | $8.88B | $52.20B |
Volume | 1,028,790 | 8,032,866 |
Sector | Health | Real Estate |
52-Week High | $127.31 | $67.56 |
52-Week Low | $55.80 | $53.35 |
Typical Hold Time | 0 Days | 128 Days |
Enterprise Value | $8.27B | $82.83B |
Dividend Yield | — | 5.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Realty Income (O) trades at $54.99, up 0.53% on the day, with a bearish technical signal and recent earnings misses. The REIT shows strong revenue growth, reaching $5.75B in 2025, and maintains high gross margins above 92%, but faces pressure from rising debt levels and interest expenses. Analyst consensus is a Buy with a $64.16 price target, though recent news highlights underperformance versus the S&P 500 and sensitivity to Treasury yield increases.
The stock offers a defensive income play with a history of dividend growth, but investors face risks from elevated valuation multiples, consecutive EPS misses, and macroeconomic headwinds. Upside depends on execution amid high leverage and competitive REIT markets, with the current price reflecting cautious sentiment despite long-term fundamentals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →
